BUZZ-Australia's Recce Pharmaceuticals hits 1-week high on $56.5 mln R&D boost
Reuters2025-12-16
BUZZ-Australia's <a href="https://laohu8.com/S/RECEF">Recce Pharmaceuticals</a> hits 1-week high on $56.5 mln R&D boost** Shares of Australia's Recce Pharmaceuticals RCE.AX rise as much as 3.3%, their highest since December 8
** The pharmaceutical co receives Advanced Overseas Finding approval for up to A$85 million ($56.47 million) for Synthetic Antibiotic R&D
** Co receives confirmation that its R&D activities undertaken outside Australia are eligible and qualify for the 43.5% R&D Tax Incentive
** RCE up 28% YTD
($1 = 1.5053 Australian dollars)
(Reporting by Keshav Singh Chundawat in Bengaluru)
((Keshav.singhchundawat@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
